Acumen Pharmaceuticals (ABOS)
US Market

Acumen Pharmaceuticals (ABOS) Stock Price & Analysis


ABOS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.02 - $10.97
Previous Close$4.01
Average Volume (3M)80.26K
Market Cap
Enterprise Value-$27.77M
Total Cash (Recent Filing)$200.19M
Total Debt (Recent Filing)$133.00K
Price to Earnings (P/E)-3.8
May 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding40,925,284
10 Day Avg. Volume125,687
30 Day Avg. Volume80,258
Standard Deviation0.28
Financial Highlights & Ratios
Price to Book (P/B)0.82
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-0.66
Price Target Upside315.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Acumen Pharmaceuticals’s price range in the past 12 months?
Acumen Pharmaceuticals lowest stock price was $3.02 and its highest was $10.97 in the past 12 months.
    What is Acumen Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Acumen Pharmaceuticals’s upcoming earnings report date?
    Acumen Pharmaceuticals’s upcoming earnings report date is May 15, 2023 which is in 47 days.
      How were Acumen Pharmaceuticals’s earnings last quarter?
      Acumen Pharmaceuticals released its earnings results on Mar 27, 2023. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.275 by -$0.045.
        Is Acumen Pharmaceuticals overvalued?
        According to Wall Street analysts Acumen Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Acumen Pharmaceuticals pay dividends?
          Acumen Pharmaceuticals does not currently pay dividends.
          What is Acumen Pharmaceuticals’s EPS estimate?
          Acumen Pharmaceuticals’s EPS estimate is -$0.33.
            How many shares outstanding does Acumen Pharmaceuticals have?
            Acumen Pharmaceuticals has 41,025,063 shares outstanding.
              What happened to Acumen Pharmaceuticals’s price movement after its last earnings report?
              Acumen Pharmaceuticals reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.275. Following the earnings report the stock price went up 7.398%.
                Which hedge fund is a major shareholder of Acumen Pharmaceuticals?
                Among the largest hedge funds holding Acumen Pharmaceuticals’s share is RA Capital Management. It holds Acumen Pharmaceuticals’s shares valued at 53M.


                  Acumen Pharmaceuticals Stock Smart Score

                  The Acumen Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Acumen Pharmaceuticals

                  Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.


                  Top 5 ETFs holding ABOS

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold ABOS. The ETFs are listed according to market value of ABOS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Lineage Therap
                  Gritstone Oncology

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis